Tumor necrosis factor-alfa in nonhealing venous leg ulcers

Journal of the American Academy of Dermatology

Volumn 60, Issue 6, 2009, Pages 951-955

  Charles, Carlos A ^a   Romanelli, Paolo ^a   Martinez, Zuleika Bonilla ^a   Ma, Fangchao ^a   Roberts, Brenda ^a   Kirsner, Robert S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEG ULCER; MALE; PRIORITY JOURNAL; PUNCH BIOPSY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCORING SYSTEM; WOUND HEALING;

AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SKIN; TUMOR NECROSIS FACTOR-ALPHA; VARICOSE ULCER;

EID: 67349202787     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2008.09.012     Document Type: Article

References (25)

1. Valencia I.C., Falabella A., Kirsner R.S., and Eaglstein W.H. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol 44 (2001) 401-421
2. Ruckley C.V. Socio-economic impact of chronic venous insufficiency and leg ulcers. Angiology 48 (1997) 67-69
3. Falanga V., Margolis D., Alvarez O., Auletta M., Maggiacomo F., Altman M., et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 134 (1998) 293-300
4. Phillips T.J., Machado F., Trout R., Porter J., Olin J., and Falanga V. Prognostic indicators in venous ulcers. J Am Acad Dermatol 43 (2000) 627-630
5. Phillips T.J. Successful methods of treating venous ulcers: the tried and true, plus the novel and new. Postgrad Med J 105 (1999) 159-179
6. Trengove N.J., Stacey M.C., MacAuley S., Bennett N., Gibson J., Burslem F., et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 7 (1999) 442-452
7. Margolis D.J., Berlin J.A., and Strom B.L. Which venous leg ulcers will heal with limb compression bandages?. Am J Med 109 (2000) 15-19
8. Mori R., Kondo T., Ohshima T., Ishida Y., and Mukaida N. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J 16 (2002) 963-974
9. Wysocki A.B., Staiano-Coico L., and Grinnell F. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101 (1993) 64-68
10. Chen S.M., Ward S.I., Olutoye O.O., Diegelmann R.F., and Kelman Cohen I. Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors. Wound Repair Regen 5 (1997) 23-32
11. Tarnuzzer R.W., and Schultz G.S. Biochemical analysis of acute and chronic wound environments. Wound Repair Regen 4 (1996) 321-325
12. Jones E., Stuart D., and Walker N. Structure of tumour necrosis factor. Nature 338 (1989) 225-228
13. Jue D.M., Sherry B., Luedke C., Manogue K.R., and Cerami A. Processing of newly synthesized cachetin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemistry 29 (1990) 8371-8377
14. Schütze S., Scheurich P., Schlüter C., Ucer U., Pfizenmaier K., and Krönke M. Tumor necrosis factor-induced changes of gene expression in U937 cells. Differentiation-dependent plasticity of the responsive state. J Immunol 140 (1988) 3000-3005
15. Vilcek J., Palombella V., Henrikson-DeStefano D., Swenson C., Feinman R., Hirai M., et al. Fibroblast enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J Exp Med 163 (1986) 632-643
16. Detmar M., and Orfanos C. Tumor necrosis factor-alpha inhibits cell proliferation and induces class II antigens and cell adhesion molecules in cultured normal keratinocytes in vitro. Arch Dermatol Res 282 (1990) 238-245
17. Polunovsky V., Wendt C., and Ingbar D. Inducuction of endothelial cell apoptosis by TNF alpha: modulation and inhibitors of protein synthesis. Exp Cell Res 214 (1994) 584-594
18. Mirshahi S., Soria J., Mirshahi M., Soria C., Lenoble M., Vasmant D., et al. Expression of elastase and fibrin in venous leg ulcer biopsies: a pilot study of pentoxyfilline versus placebo. J Cardiovasc Pharmacol 25 Suppl 2 (1995) S101-S105
19. Wallace H.J., and Stacey M.C. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers-correlations to healing status. J Invest Dermatol 110 (1998) 292-296
20. Murphy M.A., Joyce W.P., Condron C., and Bouchier-Hayes D. A reduction in serum cytokine levels parallels healing of venous ulcers in patients undergoing compression therapy. Eur J Vasc Surg 23 (2002) 349-352
21. Wallace H.J., Vandongen Y.K., and Stacey M.C. Tumor necrosis factor α gene polymorphism associated with increased susceptibility to venous leg ulceration. J Invest Dermatol 126 (2006) 923-926
22. Brooklyn T.N., Dunnill M.G., Shetty A., Bowden J.J., Williams J.D., Griffiths C.E., et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 55 (2006) 505-509
23. Charles C.A., Leon A., Banta M.A., and Kirsner R.S. Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series. Int J Dermatol 46 (2007) 1095-1099
24. Cowin A.J., Hatzirodos N., Rigden J., Fitridge R., and Belford D.A. Etanercept decreases tumor necrosis factor-alpha activity in chronic wound fluid. Wound Repair Regen 14 (2006) 421-426
25. Itamar G., Müller E., Schiefelbein D., Christen U., Pfeilschifter J., Mühl H., et al. Systemic anti-TNFα treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 127 (2007) 2259-2267